TRDA
Entrada Therapeutics Inc
NASDAQ: TRDA · HEALTHCARE · BIOTECHNOLOGY
$14.50
+7.41% today
Updated 2026-05-01
Market cap
$503.12M
P/E ratio
—
P/S ratio
19.79x
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$5 – $14
Volume
0.2M
Entrada Therapeutics Inc (TRDA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,103.00%
ROE
-39.10%
ROA
-21.60%
Debt/equity
0.15x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.65M | — | — | — |
| 2020 | $0.00 | $-26.52M | — | — | — |
| 2021 | $0.00 | $-50.07M | — | — | — |
| 2022 | $25.26M | $-87.46M | -7.50% | -384.99% | -346.23% |
| 2023 | $129.01M | $-6.68M | 100.00% | -2.45% | -5.18% |
| 2024 | $210.78M | $65.63M | 100.00% | 22.30% | 31.13% |
| 2025 | $25.42M | $-143.75M | 83.89% | -613.66% | -565.48% |